Dr. Paurush Babbar of The Urology Group talks with Lincoln Ware of The Buzz 1230AM about Low-T therapies, breaking down myths and misconceptions.
Dr. Gary Kirsh, president of The Urology Group in Cincinnati and Market President for Solaris Health, talks about prostate cancer prevalance. He, and other top urologists, are concerned about a growing trend in patients presenting with advanced prostate cancer. They attribute it to two key factors: the Pandemic and men delaying screenings as well as a government recommendation in 2018 to slow screenings.
The Urology Group seeks to help patients with advanced prostate cancer find drugs like Pluvicto that are in short supply. One patient received his medication from Italy due to limited quantities in the U.S. Being your own advocate is essential to making sure you can take advantage of every treatment option available.
A recent article in Romper Magazine revealed that although vasectomies are simpler, safer, and less expensive, tubal ligations (getting one’s “tubes tied”) outpace them 3 to 1 in the United States and are still performed far more often worldwide. In this article The Urology Group’s Dr. Paurush Babbar debunks common myths and fears men have about getting a…